Skip to main content
OpenTrials
Completed

NCT Number: NCT02174042

The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis

The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

General Disorders and Administration Site Conditions

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Nanmeng Tianyuan hospital; Dongfang Hospital; China-Japanese Friendship Hospital

Beijing Shi, Guizhou, 510000, China

About this study

The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule,a traditional Chinese Miao medicine, in Type 2 Diabetics.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosis of type 2 diabetes for more than one year.
  • the sustained follow-up time >3 month.
  • TNTL single or combined treatment time >3 month.
  • Chinese ethnicity.

Exclusion criteria

  • the medical record information is not original and available.
  • lactating or pregnant.
  • diagnosis of heart failure, acute myocardial infarction, stroke, or serious injuries.
  • any other conditions not suitable for trial as evaluated by the physician in charge.

Treatment and study plan

Tangning Tongluo Capsule

Drug

Taken drugs 3 times a day, with each time 3 grains

Other names: TNTL Capsule

Primary outcomes

  1. The Changing (%) of Blood Glucose Level and Glycosylated Hemoglobin Level from Baseline

    Time frame: At least 3 months

    The Changing (%) of Blood Glucose Level (mmol/L) and Glycosylated Hemoglobin Level (%) from Baseline (start using Tang Ning Tong Luo capsule) in recruited Type 2 diabetes patients.

Secondary outcomes

  1. The Number of Participants with Adverse Events Using Tangning Tongluo Capsule

    Time frame: At least 3 months

    The Number of Participants with Adverse Events Using Tangning Tongluo Capsule in the Treatment ofType II Diabetes

Other outcomes

  1. Number of adverse events in recruited patients.

    Time frame: At least 3 months

    Number of adverse events in recruited patients.

Sponsors and collaborators

Lead sponsor

Guizhou Bailing Group Pharmaceutical Co Ltd

Industry

Registry information

Official study title

The Effect of Tang Ning Tongluo Formula, a Traditional Chinese Miao Medicine, in Type 2 Diabetics: A Retrospective Clinical Analysis

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Jun 25, 2014
Registry last updated
Sep 11, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.